[PDF][PDF] Preoperative prediction of poor prognostic parameters and adjuvant treatment in women with pure endometrioid type endometrial cancer: what is the …

E Baser, T Gungor, C Togrul… - Eur. J. Gynaec. Oncol …, 2014 - article.imrpress.com
Purpose of the study: The study was conducted to determine whether preoperative serum
levels of cancer antigen (CA) 125, CA15-3, CA19-9, carcinoembryonic antigen (CEA), and …

Histological and immunohistochemical profiles predict lymph node status in women with low-intermediate risk endometrial cancer

M Ballester, G Canlorbe, A Cortez, J Gonin, E Laas… - Gynecologic …, 2013 - Elsevier
Objective The aim of this study was to build a model to predict the risk of lymph node
metastases (LNM) in women with low-or intermediate-risk endometrial cancer (EC) using …

Prediction of lymph node and distant metastasis in patients with endometrial carcinoma: a new model based on demographics, biochemical factors, and tumor …

A Luomaranta, A Leminen, M Loukovaara - Gynecologic oncology, 2013 - Elsevier
OBJECTIVE: To develop a model that might predict the probability of lymph node and distant
metastasis (stages IIIC–IV) in endometrial carcinoma. METHODS: We studied 774 patients …

Analysis of factors related to lymph node metastasis in early-stage type 1 endometrial cancer: verifying the clinical value of positive threshold of the …

P Jiang, R Yuan - Cancer Management and Research, 2021 - Taylor & Francis
Objective Lymph node metastasis (LNM) is an important reference indicator for the
prognosis of endometrial cancer (EC). Even in patients with early low-risk EC, many people …

[PDF][PDF] CA-125/CeA ratio as a prognostic factor in type II endometrial cancer: a single institute experience

İ Karadağ, S Karakaya, Ö Ateş… - World Cancer Research …, 2022 - wcrj.net
Objective: Type II (non-endometrioid) endometrial cancer is less common with an incidence
of 10%-20%. It has an aggressive clinical course with heterogeneous clinic pathological …

[HTML][HTML] Improved preoperative risk stratification with CA-125 in low-grade endometrial cancer: a multicenter prospective cohort study

C Reijnen, NCM Visser, JC Kasius, D Boll… - Journal of …, 2019 - ncbi.nlm.nih.gov
Objectives The global obesity epidemic has great impact on the prevalence of low-grade
endometrial carcinoma. The preoperative tumor serum marker cancer antigen 125 (CA-125) …

Evaluation of preoperative criteria used to predict lymph node metastasis in endometrial cancer

SS Han, SH Lee, DH Kim, JW Kim… - Acta obstetricia et …, 2010 - Taylor & Francis
Objective. To evaluate whether we could accurately predict lymph node (LN) metastasis with
preoperative tests in endometrial cancer. Design. Retrospective study. Setting. Seoul …

Predicting model of lymph node metastasis using preoperative tumor grade, transvaginal ultrasound, and serum CA-125 level in patients with endometrial cancer

J Lee, TW Kong, J Paek, SJ Chang… - International Journal of …, 2016 - ijgc.bmj.com
Objective The purpose of this study was to evaluate the predicting model for lymph node
metastasis using preoperative tumor grade, transvaginal sonography (TVS), and serum …

[HTML][HTML] Preoperative CA125 and fibrinogen in patients with endometrial cancer: a risk model for predicting lymphovascular space invasion

X Zhou, H Wang, X Wang - Journal of gynecologic oncology, 2017 - ncbi.nlm.nih.gov
Objective The aim of this study was to build a model to predict the risk of lymphovascular
space invasion (LVSI) in women with endometrial cancer (EC). Methods From December …

Quantitative measurement of progesterone receptor immunohistochemical expression to predict lymph node metastasis in endometrial cancer

YY Hsiao, HC Fu, CH Wu, J Lan, YC Ou, CC Tsai, H Lin - Diagnostics, 2022 - mdpi.com
Background: Previous studies have shown that loss of progesterone receptor (PR) in
endometrial cancer (EC) is associated with poor outcomes. Evaluating lymph node …